Home / Business and Economy / Japan to Add Extra Costs to Common Rx Drugs
Japan to Add Extra Costs to Common Rx Drugs
12 Jan
Summary
- 77 ingredients in prescription drugs will incur extra patient costs.
- Measure aims for fairness and to reduce insurance burden.
- Additional fees start March 2027; some groups exempt.

Starting March 2027, Japan plans to implement additional patient charges on around 1,100 prescription medications that contain 77 specific ingredients. These "OTC-like drugs" are similar in composition and effect to over-the-counter products but have been covered by public health insurance. The Ministry of Health, Labor and Welfare announced this proposal to ensure fairness for individuals purchasing over-the-counter medicines and to lessen the financial strain on the working population through insurance premiums.
The new system will require patients to pay an additional "special fee" of 25% of the drug cost, on top of their usual 10% to 30% copayment, with public insurance covering the remaining 75%. This change is expected to increase costs for patients with a 30% copayment to approximately 1.6 times their current expense. The ministry estimates this measure will reduce national medical expenses by about 90 billion yen annually.




